Espoo — Euformatics, a Finnish bioinformatics company that develops world-leading NGS interpretation and quality control tools, announced that it has signed a new commercial partnership with ELTA 90. As part of the collaboration, ELTA 90 and Euformatics plan to locally market the complex clinical diagnostic and genomic testing tools of Euformatics, to benefit the medical […]
San Francisco, CA — Illumina Ventures today announced that Mara Aspinall, MBA, has joined the Company’s investment team as a Partner. “Mara brings more than 30 years of leadership experience in genomics and the diagnostics industry to this position,” said Nick Naclerio, PhD, Illumina Ventures Founding Partner. “Her experience ranges from early-stage start-ups to established public […]
> Dante to utilize Amazon Bedrock to build state-of-the-art large language model (LLM) with broad genomic and clinical applications – > Amazon Bedrock will leverage Dante’s expertise with clinical interpretation and massive whole genome database – > Groundbreaking collaboration pioneering the use case for LLMs in personalized medicine, enabling extraction of phenotypes of interest to […]
The GlutenTox® ELISA Rapid G12 test kit offers a systematic method for evaluating gluten content from wheat, barley and rye in food samples. Its precision and reliability have earned it the AOAC RI Performance Tested MethodsSM certification. The kit aligned with AOAC’s exacting standards, confirming its capability to accurately detect and quantify wheat gluten in a variety of […]
Manufacture of quality-critical materials for the fast-growing and increasingly relevant market segment of cell and gene therapies Groundbreaking event in the Haid-Süd industrial park with around 150 guests Total investment of around 140 million euros Number of jobs can be more than doubled Freiburg, Germany — The life science group Sartorius is building a new […]
10x Wins Injunction From Unified Patent Court Banning Sales of NanoString’s CosMx Products in Europe
Second Injunction Issued Against CosMx PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that the European Unified Patent Court (“UPC”) issued a preliminary injunction against NanoString Technologies, Inc. (Nasdaq: NSTG) for infringing European Patent 4 108 782 B1 (“the EP 782 patent,” docket No 459746/2023). The preliminary injunction, issued […]
Deepcell Expands Commercial Capabilities Hiring Mark Aitkenhead, Ph.D., as Chief Commercial Officer MENLO PARK, Calif. – Deepcell, a pioneer in artificial intelligence (AI)-powered single-cell analysis to fuel deep biological discoveries, today announced the appointment of Mark Aitkenhead, Ph.D., to the newly created position of Chief Commercial Officer. “We are delighted to welcome Dr. Aitkenhead to our […]
NanoString Will Immediately Appeal Preliminary Injunction Temporarily Blocking NanoString’s Ability to Market and Sell CosMx Spatial Molecular Imager Products for RNA Detection within UPC Member Countries in Europe SEATTLE — NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, commented on today’s order from the European Unified […]
Agilent Technologies Inc. (NYSE: A) recently signed a Research Collaboration Agreement (RCA) with the National Cancer Centre Singapore (NCCS) outlining their collaboration to accelerate translational cancer research on the genomic landscape of Asian-prevalent cancers over the next two years. The scope of the agreement includes the supply of an Agilent Magnis Next-Generation Sequencing (NGS) Preparation System to […]
Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only test SALT LAKE CITY — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
